Multicenter Descriptive Study of the Patient Clinical Profile That Begins With Disseminated Her 2 + Breast Cancer or Develops a Metastasis After or During the Adjuvant Therapy (PRIMHER)
Observational, Cross-sectional, Multicenter Descriptive Study of the Patient Clinical Profile That Begins With Disseminated Her 2 + Breast Cancer or Develops a Metastasis After or During the Adjuvant Therapy (PRIMHER)
연구 개요
상태
상태
정황
정황
연구 유형
연구 유형
등록 (실제)
등록
연락처 및 위치
연구 장소
-
-
-
Almería, 스페인, 04009
- Hospital de Torrecardenas
-
Badajoz, 스페인, 06008
- Hospital Infanta Cristina de Badajoz
-
Barcelona, 스페인, 08017
- Clínica Corachan
-
Ciudad Real, 스페인, 13005
- Complejo Hospitalario Ciudad Real
-
Cáceres, 스페인, 10003
- Hospital San Pedro Alcántara
-
León, 스페인, 24008
- Hospital de León
-
Lleida, 스페인, 25198
- Hospital Universitario Arnau de Vilanova
-
Lugo, 스페인, 27003
- Hospital Lucus Augusti
-
Madrid, 스페인, 28006
- Hospital La Princesa
-
Murcia, 스페인, 30008
- Hospital Morales Messeguer
-
Segovia, 스페인, 40002
- Hospital General de Segovia
-
Sevilla, 스페인, 41009
- Hospital Virgen de la Macarena
-
Valencia, 스페인, 46014
- Hospital General Universitario de Valencia
-
Valencia, 스페인, 46017
- Hospital Dr.Peset
-
Valladolid, 스페인, 47012
- Hospital Universitario Río Hortega
-
Valladolid, 스페인, 47005
- Hospital Clínico de Valladolid
-
Zamora, 스페인, 49021
- Hospital de Zamora
-
-
Alicante
-
Denia, Alicante, 스페인, 03700
- Hospital de Denia
-
Elda, Alicante, 스페인, 03600
- Hospital General de Elda
-
-
Asturias
-
Gijón, Asturias, 스페인, 33203
- Hospital de Cabueñes
-
-
Badajoz
-
Don Benito, Badajoz, 스페인, 06400
- Hospital don Benito
-
Llerena, Badajoz, 스페인, 06900
- Hospital de Llerena
-
Mérida, Badajoz, 스페인, 06800
- Hospital de Mérida
-
-
Barcelona
-
Badalona, Barcelona, 스페인, 08916
- Ico Badalona
-
Hospitalet de Llobregat, Barcelona, 스페인, 08906
- Hospital General de l'Hospitalet
-
-
Cáceres
-
Plasencia, Cáceres, 스페인, 10600
- Hospital Virgen Del Puerto
-
-
Cádiz
-
Jerez de la Frontera, Cádiz, 스페인, 11404
- Hospital de Jerez
-
-
Islas Baleares
-
Palma de Mallorca, Islas Baleares, 스페인, 07198
- Hospital Son Llatzer
-
-
Madrid
-
Getafe, Madrid, 스페인, 28901
- Hospital de Getafe
-
Leganés, Madrid, 스페인, 28911
- Hospital Severo Ochoa
-
Móstoles, Madrid, 스페인, 28935
- Hospital De Mostoles
-
Pozuelo de Alarcón, Madrid, 스페인, 28223
- Hospital Quirón
-
-
Navarra
-
Tudela, Navarra, 스페인, 31500
- Hospital Reina Sofía de Tudela
-
-
Pontevedra
-
Vigo, Pontevedra, 스페인, 36214
- Hospital Do Meixoeiro
-
-
Tenerife
-
La Laguna, Tenerife, 스페인, 38320
- Hospital Universitario de Canarias
-
Santa Cruz de Tenerife, Tenerife, 스페인, 38010
- Hospital Universitario de la Candelaria
-
-
Teruel
-
Alcañiz, Teruel, 스페인, 44600
- Hospital de Alcañiz
-
-
Vizcaya
-
Galdakao, Vizcaya, 스페인, 48960
- Hospital de Galdakao
-
-
Álava
-
Vitoria, Álava, 스페인, 01009
- Hospital de Txagorritxu
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- Women with 18 years or over
- Patients with disseminated breast cancer histologically or cytological confirmed, who begins with Her 2+ metastatic breast cancer or develops a metastasis after or during the adjuvant therapy
- Patients treated in first line treatment in metastatic disease.
- Patients who have positive Her 2 receptor test
- Patients who have given their written informed consent
Exclusion Criteria:
- Patients who are participating in other studies
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
The Patient Clinical Profile (General Clinical Data and Breast Cancer Characteristics)
기간: 1 day (there is no follow-up, it is a cross-sectional study)
|
General clinical data: age, weigh, height, Perfomance Status (ECOG Eastern Cooperative Oncology Group, runs from 0 to 5, with 0 denoting perfect health and 5 death), Breast cancer characteristics: familiar history of breast cancer, initial diagnostic (localized or disseminated), age at diagnostic, TNM (tumor node metástasis), tumor size, node involvement, primary tumor surgery, HER2 overexpression, histological Classification (grades I, II and III,determines the urgency and aggressiveness of treatment, as the higher grades do tend to correspond to poorer survival rates and prognosis), time from the primary breast cancer to distant relapse, description and localization of metastasis
|
1 day (there is no follow-up, it is a cross-sectional study)
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Adjuvant Treatment in Primary Breast Cancer: Chemotherapy (Treatment With TAC-Docetaxel, Adriamicine and Cyclophosphamide), Hormonal Therapy Anti-HER Biological Therapy
기간: one day (there is no follow-up, it is a cross-sectional study)
|
one day (there is no follow-up, it is a cross-sectional study)
|
|
|
The Pattern of Treatment in Metastatic Breast Cancer: Chemotherapy, Hormonal Therapy Anti-HER Biological Therapy
기간: one day (there is no follow-up, it si a cross-sectional study)
|
one day (there is no follow-up, it si a cross-sectional study)
|
|
|
Adjuvant Treatment and Age
기간: one day (there is no follow-up, it is a cross-sectional study)
|
Adjuvant treatment and clinical profile (age) The patients analysed in this outcome are patients initially diagnosed with localized breast cáncer (N=66) |
one day (there is no follow-up, it is a cross-sectional study)
|
|
Adjuvant Treatment-Physical Activity
기간: one day (there is no follow-up, it is a cross-sectional study)
|
Adjuvant treatment and clinical profile (Physical activity) The patients analysed in this outcome are patients initially diagnosed with localized breast cáncer (N=66) |
one day (there is no follow-up, it is a cross-sectional study)
|
|
Adjuvant Treatment-Node Affectation
기간: one day (there is no follow-up, it is a cross-sectional study)
|
Adjuvant treatment and clinical profile (Node affectation) The patients analysed in this outcome are patients initially diagnosed with localized breast cáncer (N=66) |
one day (there is no follow-up, it is a cross-sectional study)
|
|
Disseminated Breast Cancer Treatment-Age
기간: one day (there is no follow-up, it is a cross-sectional study)
|
Analyse disseminated Breast Cancer treatment and clinical profile (age)
|
one day (there is no follow-up, it is a cross-sectional study)
|
|
Disseminated Breast Cancer Treatment-physical Activity
기간: one day (there is no follow-up, it is a cross-sectional study)
|
Analyse disseminated Breast Cancer treatment and clinical profile (physical activity)
|
one day (there is no follow-up, it is a cross-sectional study)
|
|
Disseminated Breast Cancer Treatment-Smoking
기간: one day (there is no follow-up, it is a cross-sectional study)
|
Analyse disseminated Breast Cancer treatment and clinical profile (Smoking)
|
one day (there is no follow-up, it is a cross-sectional study)
|
공동 작업자 및 조사자
스폰서
스폰서
수사관
수사관
- 수석 연구원: Mª Helena López Ceballos, MD, Hospital San Pedro Alcántara
- 수석 연구원: Santiago González Santiago, MD, Hospital San Pedro Alcántara
연구 기록 날짜
연구 주요 날짜
연구 시작
연구 시작
기본 완료 (실제)
기본 완료
연구 완료 (실제)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .